Ista Pharmaceuticals, Inc. (ISTA) Income Statement

Click line-items for a historical chart and %

Product sales, net	34.01M
Total revenues	34.01M
Cost of products sold	-2.26M
Gross profit	36.28M
Research and development	9.49M
Selling, general and administrative	28.4M
Total costs and expenses	37.89M
Income (loss) from operations	-1.61M
Interest expense	-1.44M
Gain on derivative valuation	-1.75M
Gain (loss) on warrant valuation	-13.01M
Total other income (expense)	-16.19M
Net income (loss)	-17.81M
Net income (loss) per common share, basic
Shares used in computing net income (loss) per common share, basic
Net income (loss) per common share, diluted
Shares used in computing net income (loss) per common share, diluted

Entities mentioned with ISTA

View All Entities